Description
Cefixime Dispersible Tablets (100 mg / 200 mg)
Healthy Inc is a specialized global supplier and exporter of advanced anti-infectives, pediatric medicine, and targeted 3rd-generation cephalosporin therapeutics. We provide ultra-high-purity, kinetically optimized Cefixime Dispersible Tablets (100 mg / 200 mg), manufactured in WHO–GMP certified, dedicated Beta-Lactam high-containment facilities. This “3rd-Generation Cephalosporin & Enteric Specialist” is a massive-volume, highly strategic export to pediatric hospitals, infectious disease clinics, and government health ministries, serving as the globally mandated intervention for Typhoid Fever, Urinary Tract Infections (UTI), and Respiratory Tract Infections.
Product Overview
This formulation operates as a structural saboteur of resilient Gram-negative bacteria. Cefixime is uniquely recognized for its high stability against $\beta$-lactamases and its exceptional penetration into the gallbladder and intestinal tissues, making it the premier oral treatment for Enteric Fever.
Mechanism 1 (The PBP-3 Blockade): Cefixime binds aggressively to Penicillin-Binding Proteins (PBPs), specifically targeting PBP-3 of Gram-negative bacilli. This halts the final transpeptidation step of peptidoglycan synthesis, causing the bacterial cell wall to collapse under osmotic pressure.
Mechanism 2 (The Enteric Specialist): Unlike other cephalosporins, Cefixime achieves very high concentrations in the bile and intestinal mucosa. This makes it devastatingly effective against Salmonella typhi, the causative agent of Typhoid Fever, which often hides in the gallbladder.
Mechanism 3 (The DT Kinetic Advantage): Our Dispersible Tablet (DT) technology ensures that the drug is pre-suspended in water before ingestion. This eliminates the “dissolution lag” often seen with standard hard tablets, providing a faster onset of action and ensuring 100% dose accuracy for pediatric patients.
Product Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
| Active Ingredient | Strength | Primary Clinical Function |
| Cefixime Trihydrate USP/Ph.Eur. | 100 mg / 200 mg | The Pediatric & Enteric Anchor: Dispersible format for easy administration in children and patients with dysphagia. |
| Excipients | Sweetening & Flavoring Agents | Compliance Engineering: Formulated with high-grade fruit flavors and non-cariogenic sweeteners to mask the bitter antibiotic taste, ensuring 100% pediatric compliance. |
| Disintegrants | Super-Disintegrant Blend | Instant-Dispersible Matrix: Engineered to shatter and form a smooth, grit-free suspension in < 45 seconds when placed in 5-10 mL of water. |
Technical & Logistics Specifications
HS Code: 3004.20.00 (Medicaments containing antibiotics)
CAS Number: 79350-37-1 (Cefixime) / 125110-14-7 (Cefixime Trihydrate)
Dosage Form: Dispersible Tablet (DT) / Orally Disintegrating
Packaging: Alu-Alu Blisters (STRICTLY MANDATORY). Cefixime is sensitive to moisture and light. Alu-Alu packaging ensures 24-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
Dedicated Beta-Lactam Isolation: To prevent life-threatening cross-contamination, production occurs in Strictly Isolated Beta-Lactam Blocks with dedicated HVAC and HEPA filtration systems.
Micronization Technology: We utilize advanced laser-micronization to ensure the Cefixime Trihydrate particle size is optimized for maximum intestinal absorption and bioequivalence to the originator brand.
Dosage & Administration
Standard Dosing: Usually 200 mg to 400 mg daily as a single dose or divided into two doses for 7 to 14 days.
The “Water Protocol”: The tablet should be dispersed in 5-10 mL of boiled and cooled water. The resulting suspension must be consumed immediately.
Flexible Administration: Unlike some other cephalosporins, the absorption of Cefixime is not significantly affected by food, though it may be taken with meals to minimize GI upset.
Safety Warning: Strictly contraindicated in patients with cephalosporin hypersensitivity. 10% cross-reactivity risk in penicillin-allergic patients. Adjust dosage in patients with severe renal impairment ($CrCl < 20$ mL/min).
Global Export & Contract Manufacturing
Healthy Inc is a premier Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for specialized Pediatric Antibiotics and DT Formulations. Whether you are a Government Tender Supplier for typhoid eradication in Africa or a B2B Pharma Marketplace partner in Southeast Asia, we ensure secure, WHO-GMP compliant delivery.
Reviews
There are no reviews yet.